Risk factors for relapse in ANCA‐associated vasculitis among patients with relapse after induction of remission with rituximab
Objective The objective of the study was to determine risk factors for relapse of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) after reinduction of remission with rituximab and discontinuation of maintenance therapy. Methods This is a post hoc analysis…